Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-25 @ 8:24 PM
Study NCT ID:
NCT05350969
Status:
COMPLETED
Last Update Posted:
2025-07-03
First Post:
2022-04-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
Sponsor:
Cardior Pharmaceuticals GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-17
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-20
First Submit QC Date:
None
Study First Post Date:
2022-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-01-06
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-07-02
Last Update Post Date:
2025-07-03
Last Update Post Date Type:
ACTUAL